Effectiveness of brief general practitioner advice and reimbursement ofpharmacotherapy for smoking cessation in primary care patients: a pilotcluster-randomised controlled trial within the North Rhine-WestphalianGeneral Practice Research Network HAFO.NRW (KOPA-HAFO)
Not Applicable
Recruiting
- Conditions
- F17Mental and behavioural disorders due to use of tobacco
- Registration Number
- DRKS00031777
- Lead Sponsor
- Institut für Allgemeinmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 288
Inclusion Criteria
currently smoking 10 or more cigarettes per day
Exclusion Criteria
terminally ill, pregnant/breastfeeding; moderate-to-severe cognitive impairment; contra-indications for the use of any smoking cessation
pharmacotherapy; insufficient command of the German language
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Our primary scientific objective is to assess, in the context of brief GP advice to stop smoking according to the ABC method, whether offering full reimbursement of the costs for smoking cessation pharmacotherapy compared with no reimbursement (i.e., current care as usual) increases abstinence from smoking after 12 weeks in smoking patients consulting their GP.<br><br>Patients from both the intervention and control groups will fill out a questionnaire in their GP practice at baseline and at 12-week follow-up. The questionnaire items are based on an ongoing national survey on the use of tobacco in the German population (Deutsche Befragung zum Rauchverhalten, DEBRA: www.debra-study.info). Furthermore, patients will verify their tobacco abstinence with an exhaled carbon monoxide test using a reliable and valid handheld tool (each practice will be equipped with a Bedfont piCO Smokelyzer).
- Secondary Outcome Measures
Name Time Method